- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04001933
CenteringPregnancy Oral Health Promotion (CPOP)
January 20, 2023 updated by: University of California, San Francisco
CenteringPregnancy Oral Health Promotion (CPOP) Clinical Trial
A five-year, Phase III, multi-site, cluster randomized controlled clinical trial will evaluate the efficacy of the CenteringPregnancy (CP) Oral Health Promotion (CPOP) intervention.
Intervention and control groups will be drawn from 6 CP sites.
Prenatal care facilitators will conduct the intervention in group prenatal care sessions.
With an average of 4 CP facilitators per site (24 facilitators), conducting 2-3 CP groups each (48-72 CP groups with 8 mother/child dyads per group), the total study population will be approximately 384 dyads.
CP facilitators will be randomly assigned to either the: 1) intervention arm and deliver the CPOP intervention; or 2) control arm and deliver the usual CP curriculum.
The CPOP intervention consists of two 15-minute modules: 1) maternal oral health (OH) and 2) infant OH.
The data collection will continue through 12 months postpartum.
For the maternal OH module, pre- and post-intervention dental exams of gingival OH and Plaque Levels, and knowledge, attitudes and behavior (KAB) questionnaires during the prenatal period will be used to assess maternal OH outcomes.
For the infant OH module, pre and post-module KAB questionnaires will be completed during the prenatal period.
Infant OH risk status - the presence of caries-causing bacteria (mutans streptococci and Lactobacilli) in saliva of both mother and infant will be assessed when the infant is 12 months of age to determine differences in study arms.
Study Overview
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Women:
- speak, read, or write in English or Spanish
- enrolled in CP prenatal group care identified as study group
- free of any condition that requires them to take antibiotic or antibacterial medication prior to dental procedures
- provide informed consent
Babies:
- healthy with no acute or chronic medical conditions, especially those conditions that may have resulted in hospitalizations and subsequent exposure to pathologic microorganisms
- free of any condition requiring antibiotic treatment currently or within the past three months.
- mothers provide informed consent for their children at baseline
Exclusion Criteria:
- none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Arm
CPOP Intervention (see below).
|
The intervention consists of two 15-minute interactive modules (maternal and infant OH), integrated into 2 group prenatal care sessions.
Led by trained prenatal care providers (facilitators), the maternal module includes discussion of common OH problems during pregnancy, importance of OH, importance and safety of OH care during pregnancy, hands-on skills-building activities of learning and practicing proper tooth brushing and self-assessment of gum health, and presentation of illustrated flossing and OH promotion guides.
The infant module includes discussion of infant oral hygiene, avoiding saliva sharing, proper nutrition, and importance of a dental visit by the first birthday.
Activities in both modules utilize separate tool kits including tooth brushes, fluoride toothpaste, and other supplies.
|
No Intervention: Control Arm
Usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in percent of periodontal probing sites that bleed upon probing
Time Frame: 12 weeks follow-up
|
Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in the percent of periodontal probing sites that bleed upon probing.
|
12 weeks follow-up
|
Change in percent of periodontal probing sites that probe at ≥4mm depth
Time Frame: 12 weeks follow-up
|
Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in the percent of periodontal probing sites that probe at ≥4mm depth.
|
12 weeks follow-up
|
Change in plaque levels at 24 sites
Time Frame: 12 weeks follow-up
|
Based on clinical dental exams conducted before the maternal oral health module and approximately 12 weeks following the maternal module, comparisons between the Intervention and Control groups will be conducted to determine differences in change in plaque levels at 24 sites (4 sites on 6 teeth) using the Plaque Index.
Each site is scored from 0-3 (0=no plaque; 3=heavy plaque), yielding a score between 0 and 72.
|
12 weeks follow-up
|
Incidence of salivary Mutans Streptococci in infants at 12 months of age
Time Frame: 1-year follow-up postpartum
|
Based on results of assays of infant saliva specimens collected at 12 months of age, comparisons between infants whose mothers were in the Intervention versus the Control groups will be conducted to determine differences in the incidence of Mutans Streptococci.
|
1-year follow-up postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in maternal oral health knowledge
Time Frame: 12 week follow-up
|
Self reported oral health knowledge questionnaire which includes 12 dichotomous items (0-1) for a total between 0 and 12 used for comparisons between the Intervention and Control groups.
|
12 week follow-up
|
Change in maternal oral health attitude
Time Frame: 12 week follow-up
|
Self reported oral health attitude questionnaire which includes 8 items scored 1-4 (1=Not at all important; 4=Very important) for a total between 8 and 32 used for comparisons between the Intervention and Control groups.
|
12 week follow-up
|
Change in maternal oral health behavior
Time Frame: 12 week follow-up
|
Self reported oral health behavior questionnaire which includes 4 items scored as either correct or incorrect (0=Incorrect; 1=Correct) for a total between 0-4 used for comparisons between the Intervention and Control groups.
|
12 week follow-up
|
Change in maternal knowledge regarding infant oral health
Time Frame: 2 week follow-up
|
Self reported infant oral health knowledge questionnaire which includes 10 dichotomous items (0-1) for a total between 0 and 10 used for comparisons between the Intervention and Control groups.
|
2 week follow-up
|
Change in maternal attitude regarding infant oral health
Time Frame: 2 week follow-up
|
Self reported infant oral health attitude questionnaire which includes 8 items scored 1-4 (1=Not at all important; 4=Very important) for a total between 8 and 32 used for comparisons between the Intervention and Control groups.
|
2 week follow-up
|
Incidence of salivary Lactobacillus in infants at 12 months of age
Time Frame: 1 year follow-up postpartum
|
Based on results of assays of infant saliva specimens collected at 12 months of age, comparisons between infants whose mothers were in the Intervention versus the Control groups will be conducted to determine differences in the incidence of Lactobacillus.
|
1 year follow-up postpartum
|
Mediation outcomes for maternal oral health are maternal oral health knowledge
Time Frame: 12 week follow-up
|
Evaluation of maternal oral health knowledge as a mediator of the association between treatment arm and plaque, probing and bleeding.
|
12 week follow-up
|
Mediation outcomes for maternal oral health are maternal oral health attitudes (importance and self-efficacy)
Time Frame: 12 week follow-up
|
Evaluation of maternal oral health attitudes as a mediator of the association between treatment arm and plaque, probing and bleeding.
|
12 week follow-up
|
Mediation outcomes for maternal oral health are maternal oral health behaviors (ADA-recommended tooth brushing practices and flossing)
Time Frame: 12 week follow-up
|
Evaluation of maternal oral health behaviors as a mediator of the association between treatment arm and plaque, probing and bleeding.
|
12 week follow-up
|
Mediation outcomes for infant oral health risk are infant oral health-related knowledge
Time Frame: 1 year follow-up postpartum
|
Evaluation of maternal knowledge of infant oral health as a mediator of the association between treatment arm and infant MS and LB.
|
1 year follow-up postpartum
|
Mediation outcomes for infant oral health risk are infant oral health-related attitudes (importance and self-efficacy)
Time Frame: 1 year follow-up postpartum
|
Evaluation of maternal attitudes toward infant oral health as a mediator of the association between treatment arm and infant MS and LB.
|
1 year follow-up postpartum
|
Mediation outcomes for infant oral health risk are infant oral health-related behaviors (importance and self-efficacy)
Time Frame: 1 year follow-up postpartum
|
Evaluation of maternal behaviors toward infant oral health as a mediator of the association between treatment arm and infant MS and LB.
|
1 year follow-up postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lisa Berens, DDS, MPH, University of California, San Francisco
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 1, 2020
Primary Completion (Anticipated)
July 1, 2022
Study Completion (Actual)
July 31, 2022
Study Registration Dates
First Submitted
June 4, 2019
First Submitted That Met QC Criteria
June 26, 2019
First Posted (Actual)
June 28, 2019
Study Record Updates
Last Update Posted (Actual)
January 23, 2023
Last Update Submitted That Met QC Criteria
January 20, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 18-029-E
- 1U01DE027340-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oral Health
-
Fernanda Muñoz SepúlvedaSubvención Presidencial, Ministerio de Hacienda, Chile; Centro Interuniversitario... and other collaboratorsCompletedOral Health Knowledge | Oral Health Attitudes | Oral Health Self-efficacyChile
-
Academia Cearense de OdontologiaCompletedOral Health | Public Health | Diagnosis, OralBrazil
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
Designs for HealthRecruitingA Pilot Study of a Commercially-available Oil Rinse Product (PerioPull™) on Markers of Dental HealthOral HealthUnited States
-
Oral Health Center of Expertise Rogaland, NorwayUniversity of Bergen; University of Agder; University of Stavanger; Regional Research...Recruiting
-
HALEONActive, not recruitingOral HealthUnited States
-
I.M. Sechenov First Moscow State Medical UniversityCompleted
-
GlaxoSmithKlineCompleted
-
Mundipharma Manufacturing Pte Ltd.Singapore Polytechnic (SP)Completed
Clinical Trials on CPOP Intervention
-
CTI BioPharmaCompletedDiffuse Large-Cell LymphomaUnited States, Germany, Canada, Italy, France
-
Biolux Research Holdings, Inc.TerminatedOrthodontic Tooth MovementCanada
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedColorectal Carcinoma | Healthy Subject | Health Status UnknownUnited States
-
University of FloridaCompletedSensitivityUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health and...RecruitingHuman Papillomavirus InfectionUnited States
-
Ohio State University Comprehensive Cancer CenterCompleted
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnCancer Survivor | Peripheral Sensory Neuropathy
-
Nottingham Trent UniversityUnknownOverweight and ObesityUnited Kingdom
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)CompletedStage 0a Bladder Cancer AJCC v8 | Stage 0is Bladder Cancer AJCC v8 | Stage I Bladder Cancer AJCC v8United States
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Prognostic... and other conditionsUnited States